Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A BottomleyEuropean Organization for Research and Treatment of Cancer Breast Cancer Group

Abstract

To compare health-related quality of life (HRQOL) in patients with metastatic breast cancer receiving the combination of doxorubicin and paclitaxel (AT) or doxorubicin and cyclophosphamide (AC) as first-line chemotherapy treatment. Eligible patients (n = 275) with anthracycline-naive measurable metastatic breast cancer were randomly assigned to AT (doxorubicin 60 mg/m(2) as an intravenous bolus plus paclitaxel 175 mg/m(2) as a 3-hour infusion) or AC (doxorubicin 60 mg/m(2) plus cyclophosphamide 600 mg/m(2)) every 3 weeks for a maximum of six cycles. Dose escalation of paclitaxel (200 mg/m(2)) and cyclophosphamide (750 mg/m(2)) was planned at cycle 2 to reach equivalent myelosuppression in the two groups. HRQOL was assessed with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 and the EORTC Breast Module at baseline and the start of cycles 2, 4, and 6, and 3 months after the last cycle. Seventy-nine percent of the patients (n = 219) completed a baseline measure. However, there were no statistically significant differences in HRQOL between the two treatment groups. In both groups, selected aspects of HRQOL were impaired over time, with increased fatigue, although some clinic...Continue Reading

References

Dec 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A CoatesJ F Forbes
May 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I C HendersonD Henry
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Osoba
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A SprangersN K Aaronson
Sep 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J GehlP Dombernowsky
Jul 2, 1997·JAMA : the Journal of the American Medical Association·A Leplège, S Hunt
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
Aug 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A KramerR Paridaens
Nov 1, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M KaufmannG Piscitelli
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J JassemUNKNOWN Central & Eastern Europe and Israel Pacitaxel Breast Cancer Study Group
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BuzdarC Brady
Sep 1, 2001·Journal of Advanced Nursing·L Hakamies-BlomqvistC Blomqvist
Feb 23, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P FayersUNKNOWN Quality of Life Unit
Mar 22, 2002·The Lancet Oncology·D M Parkin
Oct 10, 2002·The Lancet Oncology·Andrew Bottomley, Patrick Therasse

❮ Previous
Next ❯

Citations

Nov 21, 2007·Breast Cancer Research and Treatment·Nadia Harbeck, Renate Haidinger
May 16, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Julie LemieuxPamela J Goodwin
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M ClemonsA Howell
Oct 3, 2008·International Journal of Technology Assessment in Health Care·Rebecca A MiksadUwe Siebert
Jan 11, 2011·Journal of the National Cancer Institute·Julie LemieuxValérie Théberge
May 20, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah QuirkWendy L Smith
Oct 10, 2006·Annals of Surgical Oncology·Marieke J BolsterVivianne C G Tjan-Heijnen
Jan 25, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kazuhiko Sato
Nov 8, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kazuhiko Sato
Nov 8, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroyuki TakeiToshio Tabei
Jun 8, 2012·European Journal of Cancer Care·E ReedJ Hawthorn
Jun 25, 2013·International Journal of Nursing Studies·Chi-Yin KaoChing-Yu Chen
Jul 27, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BottomleyUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Data Center and Quality of Life Group
Mar 1, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hui Yi Xue, Ho Lun Wong
Mar 20, 2016·Bulletin du cancer·Jean-Sébastien FrenelPierre-Étienne Heudel
Apr 23, 2013·The Breast : Official Journal of the European Society of Mastology·Jaime Ruiz-TovarRafael Calpena
May 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah L McDonaldAndrew C Schofield
Jun 5, 2012·Cancer Treatment Reviews·Birgit E P J VriensVivianne C G Tjan-Heijnen
Nov 28, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ji-Youn HanJin Soo Lee
Jun 22, 2005·World Journal of Gastroenterology : WJG·Xiao-Ping LiJie Li
Jun 11, 2015·The Cochrane Database of Systematic Reviews·Davina GhersiNicholas Wilcken
Sep 2, 2008·Journal of Experimental & Clinical Cancer Research : CR·Ali Montazeri
Oct 24, 2007·Journal of the National Cancer Institute. Monographs·Charles S Cleeland
Mar 5, 2016·The Cochrane Database of Systematic Reviews·Elvira C van DalenLeontien C M Kremer
Sep 26, 2014·Clinical Journal of Oncology Nursing·Silvia GonellaValerio Dimonte
Sep 10, 2019·Indian Journal of Surgical Oncology·Sanjiv SrivastavaAnand K Mishra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J A KramerR Paridaens
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J A KramerR Paridaens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jose ChangCatherine Y Lau
© 2022 Meta ULC. All rights reserved